| Q37741425 | A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy |
| Q34129715 | A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients. |
| Q34168896 | A computational model to predict bone metastasis in breast cancer by integrating the dysregulated pathways |
| Q38013066 | A methodological approach to unravel organ-specific breast cancer metastasis. |
| Q36761684 | A novel gene expression signature for bone metastasis in breast carcinomas |
| Q64065803 | A specific gene expression signature for visceral organ metastasis in breast cancer |
| Q43551742 | A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network |
| Q91642406 | A three layered histone epigenetics in breast cancer metastasis |
| Q38757261 | A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis. |
| Q52597050 | ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1. |
| Q64889550 | Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer. |
| Q39436749 | Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. |
| Q55004153 | Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer. |
| Q33410835 | Biological convergence of cancer signatures |
| Q37373790 | Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases. |
| Q34129373 | Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases |
| Q33733991 | Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance |
| Q52581589 | Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun. |
| Q38704826 | Clinical value of R-spondins in triple-negative and metaplastic breast cancers |
| Q42785057 | Confounding effects in "A six-gene signature predicting breast cancer lung metastasis". |
| Q37995971 | Cooperate concept of metastasis: site-specific requirement of activated differentiation and dynamic deterioration |
| Q33516655 | Data reporting standards: making the things we use better |
| Q28731283 | Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides |
| Q37595455 | Differentially correlated genes in co-expression networks control phenotype transitions |
| Q27322590 | Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss |
| Q59808961 | Distinct expression profiles and functions of Kindlins in breast cancer |
| Q37693436 | Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting. |
| Q89665275 | Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression |
| Q26824799 | Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer |
| Q33945493 | Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells |
| Q64054816 | Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data |
| Q35168104 | Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors |
| Q34744328 | Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy |
| Q36688951 | FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies |
| Q37259958 | Feasibility of using gene expression analysis to study canine soft tissue sarcomas |
| Q92508950 | GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells |
| Q27335599 | Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule |
| Q35955416 | Gene expression in "young adult type" breast cancer: a retrospective analysis. |
| Q34192343 | Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. |
| Q38710164 | HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells |
| Q38056383 | Hide and seek: tell-tale signs of breast cancer lurking in the blood. |
| Q40614440 | INCORPORATING BIOLOGICAL INFORMATION INTO LINEAR MODELS: A BAYESIAN APPROACH TO THE SELECTION OF PATHWAYS AND GENES. |
| Q90312211 | Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data |
| Q38324305 | Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs |
| Q33942494 | Integrative network analysis reveals active microRNAs and their functions in gastric cancer |
| Q50059696 | Kindlin-1 promotes pulmonary breast cancer metastasis |
| Q92082853 | Lung-Seeking Metastases |
| Q35689467 | Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness |
| Q34766640 | Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey |
| Q42681658 | Network information improves cancer outcome prediction |
| Q28393204 | Novel genes associated with lymph node metastasis in triple negative breast cancer |
| Q48189942 | Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers |
| Q92856353 | Prediction of Bone Metastasis in Breast Cancer Based on Minimal Driver Gene Set in Gene Dependency Network |
| Q92222113 | Prognostic factors and survival outcomes according to tumor subtype in patients with breast cancer lung metastases |
| Q91867253 | RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion |
| Q35252752 | Retrospective analysis of metastatic behaviour of breast cancer subtypes |
| Q37243407 | Site-dependent differences in clinical, pathohistological, and molecular parameters in metastatic colon cancer |
| Q33761768 | Specific genomic aberrations in primary colorectal cancer are associated with liver metastases |
| Q38957273 | Substrate reduction therapy for Krabbe's disease |
| Q34049023 | Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer. |
| Q34576377 | Systems biology and genomics of breast cancer |
| Q34662610 | The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis. |
| Q37536351 | The inhibitor of kappa B kinase-epsilon regulates MMP-3 expression levels and can promote lung metastasis. |
| Q35531372 | The role of the cell-cell interactions in cancer progression |
| Q35606620 | The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin-β8 in prostate cancer cells |
| Q38399798 | Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signalling for cell proliferation. |
| Q34991710 | Translational disease interpretation with molecular networks. |
| Q34320583 | αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. |